DYNAVAX TECHNOLOGIES CORP·4

Feb 2, 7:42 PM ET

JANOWICZ ZBIGNIEW 4

4 · DYNAVAX TECHNOLOGIES CORP · Filed Feb 2, 2012

Insider Transaction Report

Form 4
Period: 2012-01-31
JANOWICZ ZBIGNIEW
CEO Dynavax Europe
Transactions
  • Award

    Option (Right to Buy)

    2012-01-31+90,00090,000 total
    Exercise: $3.48Exp: 2022-01-30Common Stock (90,000 underlying)
Footnotes (2)
  • [F1]This option grant shall vest over four (4) years with one fourth (1/4) of the Shares subject to the Option vesting twelve months after the Vesting Commencement Date, and one forty-eighth (1/48) of the Shares subject to the Option vesting on the last day of each month thereafter.
  • [F2]Not applicable.

Documents

1 file
  • 4
    rrd332107.xmlPrimary

    FORM 4